Evidence map›Paper›PMID 28533227›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.

Jennifer Beane, Sarah A Mazzilli, Anna M Tassinari, Gang Liu, Xiaohui Zhang, Hanqiao Liu, Anne Dy Buncio, Samjot S Dhillon, Suso J Platero, Marc E Lenburg and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Advances in Mapping Tumor Progression from Precancer Atlases.Cancer prevention research (Philadelphia, Pa.) · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cancer Immunoprevention: Current Status and Future Directions.Archivum immunologiae et therapiae experimentalis · 2021
    Review
  17. Lung Cancer and Immunity Markers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Jennifer BeaneDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts. jbeane@bu.edu.
Sarah A MazzilliDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Anna M TassinariDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Gang LiuDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Xiaohui ZhangDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Hanqiao LiuDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Anne Dy BuncioDepartment of Medicine, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Samjot S DhillonDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Suso J PlateroJanssen Research and Development, Spring House, Pennsylvania.
Marc E LenburgDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Mary E ReidDepartment of Medicine, Roswell Park Cancer Institute, Buffalo, New York.
Stephen LamDepartment of Medicine, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Avrum E SpiraDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Roswell Park Comprehensive Cancer Center · US

Funding

The Boston University-UCLA Lung Cancer Biomarker Development LabU01CA214182 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ABERLE, DENISE R., DUBINETT, STEVEN M. · 2016 to 2021
$3.1M
NCI NIH HHS U01 CA214182
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBronchiEpithelial CellsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansLung NeoplasmsMaleMiddle AgedNeoplasm ProteinsPrecancerous ConditionsRNA, MessengerSmokersSmokingNeoplasm ProteinsRNA, Messenger

Identifiers

PMID28533227
PMCPMC7404813
OpenAlexW2619129176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.